助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   中性粒细胞减少患者 的翻译结果: 查询用时:0.266秒
图标索引 在分类学科中查询
所有学科
更多类别查询

图标索引 历史查询
 

中性粒细胞减少患者
相关语句
  neutropenia patients
     Neutrophil antibody showd 19 of negative in 19 of 20 non-autoimmune patients, positive in 3 of 5 autoimmune patients, and positive in 2 of 6 chronic neutropenia patients.
     20例临床非自体免疫性患者中性粒细胞抗体检测19例阴性,5例自体免疫性疾病患者检测到3例阳性,6例慢性中性粒细胞减少患者2例阳性。
短句来源
  “中性粒细胞减少患者”译为未确定词的双语例句
     By the use of G-CSF-specific enzyme-linked immunosorbent assay (ELISA),the serum levels of G-CSF were determined in 40 cases with chronic CIN,40 cases with systemic lupus erythematosus (SLE) complicated neutropenia and 40 healthy volunteer (normal control) .
     采用酶联免疫吸附法(ELISA)测定CIN患者40例血清G-CSF水平,并与系统性红斑狼疮(SLE)并中性粒细胞减少患者40例及正常对照组40例血清G-CSF水平进行比较分析。
短句来源
     Bacterial spectrum and antimicrobial susceptibility pattern in in febrile neutropenic patients
     发热性中性粒细胞减少患者细菌谱及药敏分析
短句来源
     OBJECTIVE To evaluate the effect and safety of piperacillin/tazobactam on neutropenic febrile patients after receiving the chemical treatment.
     目的 评价哌拉西林 /他唑巴坦治疗化疗后中性粒细胞减少患者合并感染的疗效和安全性 ,并与头孢他啶比较。
短句来源
     Methods Blood specimens for cult - ure and susceptibility testing were collected from 128 febrile patients with neu - tropenia.
     方法对我院2003.1-2005.1收治128例发热性中性粒细胞减少患者病原菌及药敏结果进行了回顾性分析。
短句来源
  相似匹配句对
     Clinical analysis on neutropenic malignent tumor patients with infection
     恶性肿瘤患者中性粒细胞减少并感染的临床分析
短句来源
     P were analyzed retrospectively.
     P患者的资料。
短句来源
     The causes of medicine-induced neutrophilic granulocytopenia and the countermeasures
     药物性中性粒细胞减少患者病因分析及对策
短句来源
     On the Rights of Patients
     论患者的权利
短句来源
查询“中性粒细胞减少患者”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  neutropenia patients
In cyclic neutropenia patients, marked reduction in the duration of the neutropenic period was observed with rhG-CSF administration started before the period.
      
Most chronic idiopathic neutropenia patients had no real clinical problems and a normal plasma lactoferrin level.
      


The advances of pharmaclogic advantage and clinical application of the third generation of cephalosporin

介绍了头孢噻肟、头孢哌酮,拉他霉素、头孢三嗪及头孢他定等第三代头孢菌素在治疗伤寒方面的药理学优势和临床应用的进展.第三代头孢菌素治疗伤寒的主要要应症为:(1)多重耐药伤寒曹株引起的严重感染;(2)并发脑膜炎、骨髓炎、肺炎等;(3)伴有免疫缺陷或中性粒细胞减少的患者;(4)伴有肾功能不全的患者;(5)婴儿、儿童和孕产妇患者.对于多重耐药菌株所致的重症伤寒,第三代头孢菌素尚可与另一种有协同作用的抗生素联合用药.

To investigate the serum granulocyte colony-stimulating factor (G-CSF) level in patients with chronic idiopathic neutropenia (CIN) and analyze its clinical significance.By the use of G-CSF-specific enzyme-linked immunosorbent assay (ELISA),the serum levels of G-CSF were determined in 40 cases with chronic CIN,40 cases with systemic lupus erythematosus (SLE) complicated neutropenia and 40 healthy volunteer (normal control) .Results showed that serum G-CSF was positive in 11 normal controls and in 10 cases with...

To investigate the serum granulocyte colony-stimulating factor (G-CSF) level in patients with chronic idiopathic neutropenia (CIN) and analyze its clinical significance.By the use of G-CSF-specific enzyme-linked immunosorbent assay (ELISA),the serum levels of G-CSF were determined in 40 cases with chronic CIN,40 cases with systemic lupus erythematosus (SLE) complicated neutropenia and 40 healthy volunteer (normal control) .Results showed that serum G-CSF was positive in 11 normal controls and in 10 cases with SLE,and the G-CSF levels were (27.34 + 8.00)ng/L and (26.76 + 7.26)ng/L,respectively.Serum G-CSF in 27 cases with CIN was positive,the level was (134.04 + 89.29)ng/L,which was higher than that in the normal controls and the cases with SLE ( P < 0.01) .It was concluded that an obstacle to utilization of G-CSF could be existed in the patients with CIN.

检测慢性特发性中性粒细胞减少症(CIN)患者血清粒细胞集落刺激因子(G-CSP)水平并探讨其意义。采用酶联免疫吸附法(ELISA)测定CIN患者40例血清G-CSF水平,并与系统性红斑狼疮(SLE)并中性粒细胞减少患者40例及正常对照组40例血清G-CSF水平进行比较分析。结果发现,正常对照组及SLE组血清G-CSF检出率分别为11/40和10/40,两者血清G-CSF水平无差别,分别为(27.34±8.00)ng/L及(26.76±7.26)ng/L;CIN患者血清G-CSF检出率为27/40,血清G-CSF水平为(134.04±89.29)ng/L,高于正常对照组及SLE组(P<0.01)。结论:CIN患者可能存在G-CSF利用障碍。

OBJECTIVE To evaluate the effect and safety of piperacillin/tazobactam on neutropenic febrile patients after receiving the chemical treatment. METHODS Sixty patients were divided into therapeutic group and the control group randomly. The therapeutic group was treated with piperacillin/tazobactam with a dose of 4.5 g/8 h, and the control group was treated with ceftazidime with a dose of 2.0 g/12 h. All patients were treated at least 5 days or stop using the drugs after the clinical symptom and physical...

OBJECTIVE To evaluate the effect and safety of piperacillin/tazobactam on neutropenic febrile patients after receiving the chemical treatment. METHODS Sixty patients were divided into therapeutic group and the control group randomly. The therapeutic group was treated with piperacillin/tazobactam with a dose of 4.5 g/8 h, and the control group was treated with ceftazidime with a dose of 2.0 g/12 h. All patients were treated at least 5 days or stop using the drugs after the clinical symptom and physical sign of the patients vanished. RESULTS Therapeutic group showed effective rate of 81.25%, and bacteria clearance of 82.76% . The control group showed an effective rate of 57.24%, and bacteria clearance of 51.85%. CONCLUSIONS Piperacillin/tazobactam has a better effect on neutropenic febrile patients than ceftazidime.

目的 评价哌拉西林 /他唑巴坦治疗化疗后中性粒细胞减少患者合并感染的疗效和安全性 ,并与头孢他啶比较。方法 分为哌拉西林 /他唑巴坦组 (治疗组 )与头孢他啶组 (对照组 ) ,治疗组静脉滴注哌拉西林 /他唑巴坦4 .5 g,1次 / 8h,对照组静脉滴注头孢他啶针 2 .0 g,1次 / 12 h,每个患者治疗至少持续 5 d或在临床症状及体征消失 >4 8h停药。结果 治疗组治疗有效率 81.2 5 % ,细菌清除率 82 .76 % ,对照组治疗有效率 5 7.2 4 % ,细菌清除率 5 1.85 % ;统计学处理两组治疗有效率、细菌清除率差异有显著性 ( P<0 .0 5 )。结论 哌拉西林 /他唑巴坦治疗血液病化疗后粒细胞减少患者合并感染的临床疗效好、细菌清除率高、不良反应少

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关中性粒细胞减少患者的内容
在知识搜索中查有关中性粒细胞减少患者的内容
在数字搜索中查有关中性粒细胞减少患者的内容
在概念知识元中查有关中性粒细胞减少患者的内容
在学术趋势中查有关中性粒细胞减少患者的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社